These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 406769)

  • 1. The supra-additive natriuretic effect addition of theophylline ethylenediamine and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH
    Am Heart J; 1977 Aug; 94(2):168-74. PubMed ID: 406769
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment with the potent diuretic bumetanide. Permutation trial tests in patients with congestive heart failure.
    Sigurd B; Olesen KH
    Acta Med Scand; 1978; 203(1-2):113-9. PubMed ID: 343509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH; Wennevold A
    Am Heart J; 1975 Feb; 89(2):163-70. PubMed ID: 1090132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic action of bumetanide in congestive heart failure.
    Olsen KH; Sigurd B; Hesse B; Steiness E; Leth A
    Postgrad Med J; 1975; 51 Suppl 6():54-63. PubMed ID: 1105534
    [No Abstract]   [Full Text] [Related]  

  • 5. [Supra-additive natriuretic effect of theophyllamine in patients with chronic congestive heart failure during long-term therapy with bumethanide].
    Sigurd B
    Ugeskr Laeger; 1973 Oct; 135(41):2218-22. PubMed ID: 4775646
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bumetanide in heart failure in infancy.
    Ward OC; Lam LK
    Arch Dis Child; 1977 Nov; 52(11):877-82. PubMed ID: 413494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bumetanide in the treatment of congestive heart failure and arterial hypertension].
    Vichi FL; de Oliveira AC; Fariña FR; Bernardes F J; Martins JD; Mazotti L
    Arq Bras Cardiol; 1978 Aug; 31(4):277-80. PubMed ID: 727982
    [No Abstract]   [Full Text] [Related]  

  • 10. Bumetanide in congestive heart failure.
    Kourouklis C; Christensen O; Augoustakis D
    Curr Med Res Opin; 1976; 4(6):422-31. PubMed ID: 793779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose comparison of piretanide and bumetanide in congestive cardiac failure.
    Homeida M; Roberts CJ; Dombey SL
    Br J Clin Pharmacol; 1979 Aug; 8(2):173-8. PubMed ID: 385025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.
    Olesen KH; Sigurd B; Steiness E; Leth A
    Acta Med Scand; 1973; 193(1-2):119-31. PubMed ID: 4574445
    [No Abstract]   [Full Text] [Related]  

  • 13. Bumetanide: a new diuretic. Results of clinical efficacy and safety in patients with congestive heart failure.
    Handler B; Dhingra RC; Rosen KM
    J Clin Pharmacol; 1981; 21(11):691-6. PubMed ID: 7338580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of bumetanide in congestive heart failure].
    Varricchio M; Spiezia R; Giugliano D; Torella R; Giannetti G
    Farmaco Prat; 1980 Jul; 35(7):349-57. PubMed ID: 7449955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bumetanide (Burinex) --furosemide (Lasix). A comparative study in congestive heart failure].
    Michalsen H; Stokkeland M; Ditlefsen EM; Sangvik K
    Tidsskr Nor Laegeforen; 1976 Sep; 96(27):1428-9. PubMed ID: 790637
    [No Abstract]   [Full Text] [Related]  

  • 16. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.
    van Vliet AA; Donker AJ; Nauta JJ; Verheugt FW
    Am J Cardiol; 1993 Jan; 71(3):21A-28A. PubMed ID: 8422000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial of bumetanide versus furosemide in patients with congestive heart failure.
    Konecke LL
    J Clin Pharmacol; 1981; 21(11):688-90. PubMed ID: 7040496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of once-daily versus twice-daily bumetanide in heart failure.
    Hunter KR; Underwood PN
    Postgrad Med J; 1975; 51 Suppl 6():91-95. PubMed ID: 1105538
    [No Abstract]   [Full Text] [Related]  

  • 19. The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
    Olesen KH; Sigurd B
    Acta Med Scand; 1971 Sep; 190(3):233-40. PubMed ID: 4941227
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
    Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
    Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.